The chemical substance known as Butanoic acid, 3-methyl-2-(3-methyl-1-oxobutoxy)-, with the CAS number 28325-56-6, is a complex organic compound characterized by its unique structural features. It contains a butanoic acid moiety, which contributes to its classification as a carboxylic acid, and features multiple functional groups, including an ester and an oxirane (epoxide) ring. The presence of the spirocyclic structure indicates a fused ring system, which can impart specific stereochemical properties and influence its reactivity. The compound is likely to exhibit moderate solubility in organic solvents due to its hydrophobic hydrocarbon chains, while the carboxylic acid group may enhance its solubility in polar solvents. Its molecular structure suggests potential applications in pharmaceuticals or as a biochemical intermediate, although specific biological activities would depend on further empirical studies. Overall, this compound exemplifies the complexity and diversity of organic molecules, particularly those with multiple functional groups and stereochemical configurations.

Butanoic acid,3-methyl-2-(3-methyl-1-oxobutoxy)-,[(1S,2'R,4aR,6S,7aS)-6-(acetyloxy)-4a,5,6,7a-tetrahydro-4a-hydroxy-1-(3-methyl-1-oxobutoxy)spiro[cyclopenta[c]pyran-7(1H),2'-oxiran]-4-yl]methylester

28325-56-6: The chemical substance known as Butanoic acid, 3-methyl-2-(3-methyl-1-oxobutoxy)-, with the CAS number 28325-56-6, is a complex organic compound characterized by its unique structural features. It contains a butanoic acid moiety, which contributes to its classification as a carboxylic acid, and features multiple functional groups, including an ester and an oxirane (epoxide) ring. The presence of the spirocyclic structure indicates a fused ring system, which can impart specific stereochemical properties and influence its reactivity. The compound is likely to exhibit moderate solubility in organic solvents due to its hydrophobic hydrocarbon chains, while the carboxylic acid group may enhance its solubility in polar solvents. Its molecular structure suggests potential applications in pharmaceuticals or as a biochemical intermediate, although specific biological activities would depend on further empirical studies. Overall, this compound exemplifies the complexity and diversity of organic molecules, particularly those with multiple functional groups and stereochemical configurations.

VHD-valtrate has anticancer effects against human ovarian cancer cells in vitro and in vivo, it is a potential therapeutic agent for ovarian cancer, providing a

CAS 28325-56-6

Butanoic acid,3-methyl-2-(3-methyl-1-oxobutoxy)-,[(1S,2'R,4aR,6S,7aS)-6-(acetyloxy)-4a,5,6,7a-tetrahydro-4a-hydroxy-1-(3-methyl-1-oxobutoxy)spiro[cyclopenta[c]pyran-7(1H),2'-oxiran]-4-yl]methylester

IVHD-valtrate

Ref: TM-TN4341

IVHD-valtrate

Ref: BP-SBP03523